XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (XYN) is a clinical-stage biopharmaceutical company that entered the public markets through a SPAC transaction targeting the healthcare and oncology sector. The company submitted an 8-K filing with the SEC on August 27, 2019, representing a material corporate disclosure associated with its SPAC-sponsored path to listing. Xynomic's development focus centers on novel cancer therapies, placing it within the life sciences and pharmaceutical segment of the broader SPAC deal universe. For full filing history, sponsor details, deal timelines, and ongoing coverage of XYN and hundreds of other SPAC transactions, sign up for complete data access at SpacDesk.